arnicolide d has been researched along with Cancer of Prostate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Ding, M; Guo, Y; Huang, M; Lin, Y; Liu, Z; Lu, L; Shen, Q; Su, T; Yan, W; Yao, J; Yu, S; Zheng, Y | 1 |
1 other study(ies) available for arnicolide d and Cancer of Prostate
| Article | Year |
|---|---|
Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology.
Topics: Antineoplastic Agents; Asteraceae; Biological Availability; Databases, Genetic; Gene Expression Regulation, Neoplastic; Genes, src; Humans; Lactones; Male; Medicine, Chinese Traditional; Molecular Docking Simulation; Network Pharmacology; PC-3 Cells; Phytochemicals; Prostatic Neoplasms; Protein Interaction Maps; Sesquiterpenes; Signal Transduction | 2022 |